Usense
Usense is a French medtech company that sells Jimini, a CE-marked portable device enabling hospital laboratories and healthcare professionals to measure urine biomarkers in real time without consumables, supported by a secure web application and AI-aided diagnostic assistance.
- Company typePrivate
- Founded2019
- HeadquartersBoulogne-billancourt, France
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Usense does
Usense is a French medtech company founded in 2019 and headquartered in Boulogne-Billancourt, near Paris. The company develops Jimini, a portable CE-marked medical device that measures biomarkers in urine in real time at the point of care, intended for hospital laboratories and healthcare professionals. Jimini integrates a patented combination of photonic and electroanalytical technologies into an 87-gram, 21.3 cm-long probe that is immersed directly into the urine collection container without requiring consumables, then compiles a 'urine fingerprint' from raw sensor data that feeds AI-aided diagnostic assistance accessible through a secure web application.
The core product is delivered as the Jimini Experience bundle comprising the device, a secure tablet with a proprietary Android control application, a wireless charging stand, and the Usense Secure Web Application for real-time result access, fleet monitoring, and an interoperability module that transfers results to existing business software. Revenue mechanics combine upfront hardware sale of the complete Jimini solution with a recurring subscription to the secure web application and interoperability services, sold through a direct enterprise field-sales motion to hospital laboratories. Pricing is not publicly disclosed.
Usense operates within a strict regulatory and data-handling perimeter: it holds CE marking, ISO 27001, and the mandatory French HDS (Hébergeur de Données de Santé) certification for health data hosting, and has been recognized by BPI France, the French Tech label, and the Deeptech program. The company has assembled a team of roughly 20 personnel across hardware, science, data science, operations, and product, has collected 20,000 samples across 7 ongoing scientific studies, and has disclosed cumulative funding of approximately $10.5M across rounds dated 2020-2021. Revenue, post-2021 funding activity, and named reference customers are not disclosed in available materials.
Usense firmographics
Firmographics- Name
- Usense
- Legal name
- Usense
- Website
- https://usense.healthcare
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Usense is a French medtech company that sells Jimini, a CE-marked portable device enabling hospital laboratories and healthcare professionals to measure urine biomarkers in real time without consumables, supported by a secure web application and AI-aided diagnostic assistance.
- Ownership category
- akta.pro rank
Where Usense is headquartered
LocationHeadquarters
- HQ city
- Boulogne-billancourt
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Usense business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
Revenue model
- Medical Device Sales: Sale of Jimini medical device with bundled secure tablet, control application, and charging stand as a complete solution for healthcare professionals
- Software Services: Subscription-based secure web application for real-time measurement access, data management, and interoperability services for fleet monitoring
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Usense product offering
Product offeringCore offering
Usense designs and sells Jimini, a portable in vitro medical device that measures biomarkers in urine in real time using patented photonic and electroanalytical technologies. The complete commercial offering is the Jimini Experience bundle, which combines the Jimini hardware device, a secure Android tablet with pre-installed control application, and a wireless charging stand, complemented by a secure web application providing real-time measurement access, diagnostic assistance, fleet monitoring, and interoperability with healthcare business software. The product targets hospital laboratories and healthcare professionals seeking point-of-care diagnostic capability.
Product overview
Usense offers a unified medical device solution centered on Jimini, a portable urine analysis device. The portfolio comprises the Jimini hardware device (core product), the Jimini Experience bundle (device + secure tablet + control application + charging stand), a dedicated Android mobile application, and a secure web application for real-time measurement access, data transcription, and diagnostic assistance. All components are designed for healthcare professionals and operate within an interoperable digital environment.
Differentiator
Problem solved
Functional benefit
Brands
- Jimini: A revolutionary portable medical device for healthcare professionals that measures the presence of biomarkers in urine through real-time analysis using photonic and electroanalytical technologies.
Products and services
- Jimini
Quantifiable outcome
- 20 measurements per hour throughput
- +1 more outcomes
Companies that use Usense
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Usense technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature5 records
Usense partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights5 records
Usense competitors and assessment
Company assessmentEmerging players
- LumiraDx: LumiraDx built a microfluidic point-of-care platform running multiple immunoassay and chemistry tests from a single cartridge, sharing Usense's go-to-market logic of replacing centralized lab tests with a portable, connected device sold to clinicians.
- EKF Diagnostics: EKF Diagnostics manufactures point-of-care analyzers (QuikRead, STAT-Site) used in physician offices and small labs for rapid chemistry and hemoglobin testing, comparable to Usense as a smaller-scale POC device vendor serving non-centralized clinical workflows.
- QuantuMDx: QuantuMDx is developing a portable, multiplex molecular diagnostic device for decentralized use, comparable to Usense as an emerging point-of-care diagnostics platform targeting hospital and field settings with novel sensor-based measurement.
Broad incumbents
- Roche Diagnostics: Roche's cobas u 601/u 701 urine chemistry analyzers are installed globally in hospital and reference laboratories, representing the dominant legacy platform against which any new point-of-care urine biomarker device must compete for share-of-workflow.
- Beckman Coulter: Beckman Coulter (Danaher) sells the DxU Iris and iQ200 urine particle analyzers as part of its clinical chemistry portfolio, positioning it as a broad IVD incumbent serving hospital laboratories with both chemistry and microscopy workflows Usense targets.
- Siemens Healthineers: Siemens Healthineers sells the CLINITEK Status+ and CLINITEK Novus urine analyzers as part of a broad IVD menu used by hospital labs worldwide, making it the incumbent bench-top/centralized alternative Usense's Jimini is positioned to displace.
- Sysmex: Sysmex's UC-3500 and UF-5000 urine analyzers are widely deployed in hospital laboratories, making Sysmex a direct incumbent competitor on the urine biomarker workflow Usense is targeting.
- Abbott Diagnostics: Abbott's i-STAT Alinity and Afinion platforms deliver point-of-care blood and urine testing across hospitals, urgent care, and physician offices, making Abbott a natural incumbent in the decentralized diagnostic space Usense is pursuing.
Regional players
- Biosynex: Biosynex is a French-listed IVD company with a portfolio of point-of-care rapid diagnostic tests distributed across Europe and emerging markets, comparable to Usense as a French-headquartered POC diagnostics player targeting clinical and consumer health channels.
Direct peers
- Healthy.io: Healthy.io offers smartphone-based urinalysis kits (Dip.io) for home and clinical use, including FDA-cleared kidney disease screening, directly competing with Usense's vision of decentralized urine biomarker measurement outside the central lab.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Usense social profiles
Digital presenceUsense compliance and trust
Trust signalCompliance4 records
Usense financial estimates
Financial estimateRevenue estimate
Valuation estimate
Usense leadership team
Management profileNumber of profiles
Profiles9 records
Usense funding detail
Funding detailFunding overview
Funding rounds4 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Usense M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Usense
What does Usense do?
Usense designs and sells Jimini, a portable in vitro medical device that measures biomarkers in urine in real time using patented photonic and electroanalytical technologies. The complete commercial offering is the Jimini Experience bundle, which combines the Jimini hardware device, a secure Android tablet with pre-installed control application, and a wireless charging stand, complemented by a secure web application providing real-time measurement access, diagnostic assistance, fleet monitoring, and interoperability with healthcare business software. The product targets hospital laboratories and healthcare professionals seeking point-of-care diagnostic capability.
Is Usense a public or private company?
Usense is a private company. It is classified as venture growth investor backed and is currently operating.
When was Usense founded?
Usense was founded in 2019. It employs 11 to 50 people.
Where is Usense based?
Usense is headquartered in Boulogne-billancourt, France, in the Europe region.
How does Usense make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are software Services.
Who are Usense's main competitors?
Emerging players on record are LumiraDx, EKF Diagnostics and QuantuMDx. Broad incumbents are Roche Diagnostics, Beckman Coulter, Siemens Healthineers, Sysmex and Abbott Diagnostics. Biosynex is listed as a regional player. Healthy.io is listed as a direct peer.
Does Usense have an API?
No public API is recorded for Usense.